Abcam was founded by Jonathan Simon Milner.

Who are Abcam's investors?

Abcam's investors include Cambridge Angels group, Martlet Capital.

How much funding has Abcam raised?

Abcam has disclosed $800K raised across 1 round.

Abcam is headquartered in Cambridge.

Cambridge · United Kingdom LLC · 2 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the Abcam team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Supplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.

Jonathan Simon MilnerFounder

Alan Thomas HirzelExecutive

Michael Shaun BaldockNamed on SEC filing

Peter Vance AllenBoard director

Mara Glickman AspinallBoard director

Louise Alexandra Virginia Charlotte PattenBoard director

Giles Francis Bertram KerrBoard director

Form D private placements

$800K disclosed across 1 round · 2020

▶$800KraisedMar 2020 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does Abcam do?: Supplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
Who founded Abcam?: Abcam was founded by Jonathan Simon Milner.
Who are Abcam's investors?: Abcam's investors include Cambridge Angels group, Martlet Capital.
How much funding has Abcam raised?: Abcam has disclosed $800K raised across 1 round.
Where is Abcam headquartered?: Abcam is headquartered in Cambridge.